REAL-WORLD DATA ON EMICIZUMAB PROPHYLAXIS IN THE MILAN COHORT: A SINGLE-CENTER EXPERIENCE

被引：0
|
作者：
Arcudi, S. [1 ,2 ]
Gualtierotti, R. [1 ,2 ]
Ciavarella, A. [2 ,3 ]
Marino, S. [4 ]
Siboni, S. [2 ]
Biguzzi, E. [2 ]
Boccalandro, E. [2 ]
Begnozzi, V. [2 ]
Schiavone, L. [2 ]
Novembrino, C. [2 ]
Valsecchi, C. [2 ]
Peyvandi, F. [1 ,2 ]
机构：
[1] Univ Milan, Dept Pathophysiol & Transplantat, Milan, Italy
[2] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Angelo Bianchi Bonomi Hemophilia & Thrombosis Ctr, Milan, Italy
[3] Univ Milan, Dept Biomed Sci Hlth, Milan, Italy
[4] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Dept Biomed Surg & Dent Sci, Milan, Italy
来源：
HAEMOPHILIA | 2022年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PO114
引用
收藏
页码：84 / 84
页数：1
相关论文
共 50 条
  • [1] Real-World Experience with Emicizumab Prophylaxis in the Milan Cohort: A Single-Center Experience
    Arcudi, Sara
    Ciavarella, Alessandro
    Gualtierotti, Roberta
    Marino, Sonia
    Boscarino, Marco
    Siboni, Simona
    Biguzzi, Eugenia
    Schiavone, Lucia
    Novembrino, Cristina
    Valsecchi, Carla
    Peyvandi, Flora
    BLOOD, 2021, 138
  • [2] Real-world data on emicizumab prophylaxis in the Milan cohort
    Arcudi, Sara
    Gualtierotti, Roberta
    Marino, Sonia
    Nicolo, Gabriella
    Biguzzi, Eugenia
    Ciavarella, Alessandro
    Boscarino, Marco
    Siboni, Simona Maria
    Schiavone, Lucia
    Novembrino, Cristina
    Valsecchi, Carla
    Peyvandi, Flora
    HAEMOPHILIA, 2022, 28 (05) : E141 - E144
  • [3] Real-World Experience Using Emicizumab Prophylaxis for Hemophilia a: Single-Center Experience
    Vagrecha, Anshul
    Stanco, Joseph
    Ulus, Daphenee
    Acharya, Suchitra
    BLOOD, 2020, 136
  • [4] REAL-WORLD DATA ON EMICIZUMAB PROPHYLAXIS IN OLDER PERSONS WITH HEMOPHILIA A: A RETROSPECTIVE SINGLE CENTER COHORT STUDY
    Vemuru, Shalini
    Fedewa, Stacey
    Kempton, Christine
    AMERICAN JOURNAL OF HEMATOLOGY, 2024, 100 : 129 - 129
  • [5] Real-world data of prophylaxis with emicizumab in children and adolescents with severe haemophilia: A single centre experience
    Michalopoulou, A.
    Dettoraki, A.
    Karelioti, H.
    Thymianou, S.
    Papageorgiou, N.
    Stamati, I.
    Saslis, S.
    Kapsimali, Z.
    Pergantou, H.
    HAEMOPHILIA, 2024, 30 : 61 - 61
  • [6] Idarucizumab for Reversal of Dabigatran: Single-Center Real-World Experience
    Marwan Sheikh-Taha
    American Journal of Cardiovascular Drugs, 2019, 19 : 59 - 64
  • [7] Idarucizumab for Reversal of Dabigatran: Single-Center Real-World Experience
    Sheikh-Taha, Marwan
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2019, 19 (01) : 59 - 64
  • [8] PROPHYLAXIS WITH EMICIZUMAB IN 8 CHILDREN WITH HEMOPHILIA A AND INHIBITORS: REAL-WORLD DATA OF A PORTUGUESE HEMOPHILIA CENTER
    Catarino, C.
    Campanico, S.
    Rodrigues, F.
    Pereira, A.
    HAEMOPHILIA, 2020, 26 : 70 - 70
  • [9] Real-world experience of emicizumab prophylaxis in young children with hemophilia A: retrospective data from China
    Liu, Guoqing
    Huang, Kun
    Li, Gang
    Zhen, Yingzi
    Li, Zhengping
    Chen, Zhenping
    Wu, Runhui
    FRONTIERS IN PEDIATRICS, 2022, 10
  • [10] Real-world experience of novel multiple myeloma treatments in a large, single-center cohort in Finland
    Loponen, Heidi
    Mehtala, Juha
    Ylisaukko-oja, Tero
    Bruck, Oscar
    Porkka, Kimmo
    Koskenvesa, Perttu
    Saukkonen, Kirsi
    Lievonen, Juha
    EJHAEM, 2023, 4 (04): : 1019 - 1029
12345